行情

DMPI

DMPI

DelMar Pharma
NASDAQ

实时行情|Nasdaq Last Sale

0.3901
0.0000
0.00%
盘前: 0.3901 0 0.00% 09:10 04/02 EDT
开盘
--
昨收
0.3982
最高
--
最低
--
成交量
--
成交额
--
52周最高
5.75
52周最低
0.3800
市值
445.20万
市盈率(TTM)
-0.2044
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测DMPI价格均价为3.000,最高价位4.000,最低价为2.000。

EPS

DMPI 新闻

更多
  • 瑞幸咖啡报告财报审计问题:伪造交易价值约22亿元
  • 新浪科技 · 33分钟前
  • 湖北农产品,淘宝销量翻倍
  • 新浪财经 · 35分钟前
  • 瑞幸咖啡盘前跌72% 调查称伪造交易价值大约22亿元
  • 新浪财经 · 41分钟前
  • 波音向员工提出自愿离职买断计划
  • 新浪财经 · 52分钟前

所属板块

控股公司
-1.57%
金融
-6.76%

热门股票

代码
价格
涨跌幅

DMPI 简况

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being evaluated in a Phase II clinical trial for the treatment of refractory GBM. In addition to its clinical development activities in the United States, the Company has obtained certain commercial rights to VAL-083 in China where it is approved as a chemotherapy for the treatment of chronic myelogenous leukemia (CML) and lung cancer. Its drug discovery research focuses on identifying validated clinical and commercial-stage compounds, and establishing a scientific rationale for development in orphan drug indications. VAL-083 is an alkylating agent, which crosses the blood-brain-barrier (BBB).
展开

微牛提供DelMar Pharmaceuticals Inc(NASDAQ-DMPI)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的DMPI股票新闻,以帮助您做出投资决策。